Skip to main content
SpringerLink
Log in

Effect of ketoconazole on the transport and metabolism of drugs in the human liver cell model

  • Full Articles
  • Published:
Russian Chemical Bulletin Aims and scope

Abstract

The effect of ketoconazole on the biotransformation of amiodarone, rosiglitazone, and cyclophosphamide was studied using the human liver cell model based on differentiated HepaRG spheroids. The concentrations of major metabolites of amiodarone and cyclophosphamide were found to decrease in the presence of ketoconazole, a cytochrome P450 3A4 inhibitor. The concentration of the major metabolite of rosiglitazone, N-desmethyl rosiglitazone, decreased upon the addition of either sulfaphenazole, a cytochrome P450 2C9 inhibitor, or ketoconazole. The rosiglitazone metabolism involves CYP2C9 and CYP2C19. This result is attributable to the inhibitory effect of ketoconazole on p-glycoprotein, which decreases N-desmethyl rosiglitazone concentration in the culture medium. The utilization of the human liver cell model and selective inhibitors of transporters and cytochrome P450 isoforms can serve for standardization of the studies of drug-drug interactions involved in drug transport and metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S.-M. Huang, J. M. Strong, L. Zhang, K. S. Reynolds, S. Nallani, R. Temple, S. Abraham, S. Al Habet, R. K. Baweja, G. J. Burckart, S. Chung, P. Colangelo, D. Frucht, M. D. Green, P. Hepp, E. Karnaukhova, H.-S. Ko, J.-I. Lee, P. J. Marroum, J. M. Norden, W. Qiu, A. Rahman, S. Sobel, T. Stifano, K. Thummel, X.-X. Wei, S. Yasuda, J. H. Zheng, H. Zhao, L. J. Lesko, J. Clin, Pharmacol., 2008, 48,662.

    Article  CAS  Google Scholar 

  2. P. J. McDonnell, M. R. Jacobs, Ann. Pharmacother., 2002, 36, 1331.

    Article  Google Scholar 

  3. J. A. Williams, R. Hyland, B. C. Jones, D. A. Smith, S. Hurst, T. C. Goosen, V. Peterkin, J. R. Koup, S. E. Ball, Drug Metab. Dispos., 2004, 32, 1201.

    Article  CAS  Google Scholar 

  4. C. Giraud, A. Tran, E. Rey, J. Vincent, J.-M. Tréluyer, G. Pons, Drug Metab. Dispos., 2004, 32, 1279.

    CAS  Google Scholar 

  5. Guidance for Industry, Drug Interaction Studies–study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Silver Spring, 2012.

  6. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv [Guidelines for Preclinical Trials of Pharmaceutical Agents], Ed. A. N. Mironov, Grif i K, Moscow, 2012 (in Russian).

  7. J. H. Lin, M. Yamazaki, Clin. Pharmacokinet., 2003, 42,59.

    Article  CAS  Google Scholar 

  8. S. R. Faucette, R. L. Hawke, S. S. Shord, E. L. Lecluyse, C. M. Lindley, Drug Metab. Dispos., 2001, 29, 1123.

    CAS  Google Scholar 

  9. M. A. Gibbs, K. E. Thummel, D. D. Shen, K. L. Kunze, Drug Metab. Dispos., 1999, 27,180.

    CAS  Google Scholar 

  10. Y. Sai, R. Dai, T. J. Yang, K. W. Krausz, F. J. Gonzalez, H. V. Gelboin, M. Shou, Xenobiotica, 2000, 30,327.

    Article  CAS  Google Scholar 

  11. S. J. Baldwin, J. C. Bloomer, G. J. Smith, A. D. Ayrton, S. E. Clarke, R. J. Chenery, Xenobiotica, 1995, 25,261.

    Article  CAS  Google Scholar 

  12. S. S. Bun, J. Ciccolini, H. Bun, C. Aubert, J. Catalin, J. Chemother., 2003, 15,266.

    Article  CAS  Google Scholar 

  13. C. Emoto, S. Murase, Y. Sawada, B. C. Jones, K. Iwasaki, Drug Metab. Pharmacokinet., 2003, 18,287.

    Article  CAS  Google Scholar 

  14. V. Kumar, D. A. Rock, C. J. Warren, T. S. Tracy, J. L. Wahlstrom, Drug Metab. Dispos., 2006, 34, 1903.

    Article  CAS  Google Scholar 

  15. B. B. Rasmussen, T. L. Nielsen, K. Brøsen, Pharmacol. Toxicol., 1998, 83,240.

    Article  CAS  Google Scholar 

  16. E. J. Wang, K. Lew, C. N. Casciano, R. P. Clement, W. W. Johnson, Antimicrob. Agents Chemother., 2002, 46,160.

    Article  CAS  Google Scholar 

  17. J. L. Lam, L. Z. Benet, Drug Metab. Dispos., 2004, 32, 1311.

    CAS  Google Scholar 

  18. A. V. Aleksandrova, N. V. Pul´kova, D. A. Sakharov, Byul. Eksperim. Biol. Med. [Bull. Exp. Biol. Med.], 2016, 161, 60 (in Russian).

    Google Scholar 

  19. E.-M. Materne, A. P. Ramme, A. P. Terrasso, M. Serra, P. M. Alves, C. Brito, D. A. Sakharov, A. G. Tonevitsky, R. Lauster, U. Marx, J. Biotechnol., 2015, 205,36.

    Article  CAS  Google Scholar 

  20. G. Langley, C. P. Austin, A. K. Balapure, L. S. Birnbaum, J. R. Bucher, J. Fentem, S. C. Fitzpatrick, J. R. Fowle, R. J. Kavlock, H. Kitano, B. A. Lidbury, A. R. Muotri, S.-Q. Peng, D. Sakharov, T. Seidle, T. Trez, A. Tonevitsky, A. van de Stolpe, M. Whelan, C. Willett, Environ. Health Perspect., 2015, 123, A268.

    Article  Google Scholar 

  21. E.-M. Materne, A. G. Tonevitsky, U. Marx, Lab. Chip., 2013, 13, 3481.

    Article  CAS  Google Scholar 

  22. A. V. Aleksandrova, O. A. Burmistrova, K. A. Fomicheva, D. A. Sakharov, Byul. Eksperim. Biol. Med. [Bull. Exp. Biol. Med.], 2016, 161, 138 (in Russian).

    Google Scholar 

  23. D. V. Maltseva, N. A. Khaustova, N. N. Fedotov, E. O. Matveeva, A. E. Lebedev, M. U. Shkurnikov, V. V. Galatenko, U. Schumacher, A. G. Tonevitsky, J. Clin. Bioinform., 2013, 3,13.

    Article  CAS  Google Scholar 

  24. A. A. Zakharyants, O. A. Burmistrova, M. Yu. Shkurnikov, A. A. Poloznikov, D. A. Sakharov, Klet. Tekhn. Biol. Med. [Cell. Technol. Biol. Med.], 2016, 3, 208 (in Russian).

    Google Scholar 

  25. A. A. Zakharyants, O. A. Burmistrova, A. A. Poloznikov, Byul. Eksperim. Biol. Med. [Bull. Exp. Biol. Med.], 2016, 162, 517 (in Russian).

    Google Scholar 

  26. J. H. Lewis, R. C. Ranard, A. Caruso, L. K. Jackson, F. Mullick, K. G. Ishak, L. B. Seeff, H. J. Zimmerman, Hepatology, 1989, 9,679.

    Article  CAS  Google Scholar 

  27. M. E. Elsherbiny, A. O. S. El-Kadi, D. R. Brocks, J. Pharm. Pharm. Sci., 2008, 11,147.

    Article  CAS  Google Scholar 

  28. A. Zahno, K. Brecht, R. Morand, S. Maseneni, M. Török, P. W. Lindinger, S. Krähenbühl, Biochem. Pharmacol., 2011, 81,432.

    Article  CAS  Google Scholar 

  29. Q. Wu, B. Ning, J. Xuan, Z. Ren, L. Guo, M. S. Bryant, Toxicol. Lett., 2016, 253,55.

    Article  CAS  Google Scholar 

  30. K. Ohyama, M. Nakajima, S. Nakamura, N. Shimada, H. Yamazaki, T. Yokoi, Drug Metab. Dispos., 2000, 28, 1303.

    CAS  Google Scholar 

  31. S. J. Baldwin, S. E. Clarke, R. J. Chenery, Br. J. Clin. Pharmacol., 1999, 48,424.

    Article  CAS  Google Scholar 

  32. I. Bachmakov, H. Glaeser, M. F. Fromm, J. König, Diabetes, 2008, 57, 1463.

    Article  CAS  Google Scholar 

  33. S. J. Hemauer, S. L. Patrikeeva, T. N. Nanovskaya, G. D. V. Hankins, M. S. Ahmed, Am. J. Obstet. Gynecol., 2010, 202, 383.e1.

    Article  Google Scholar 

  34. J. Weiss, A. Sauer, M. Herzog, R. H. Böger, W. E. Haefeli, R. A. Benndorf, Pharmacology, 2009, 84,264.

    Article  CAS  Google Scholar 

  35. J. W. Higgins, A. B. Ke, M. J. Zamek-Gliszczynski, Drug Metab. Dispos., 2014, 42, 1780.

    Article  Google Scholar 

  36. C. Seral, J.-M. Michot, H. Chanteux, M.-P. Mingeot-Leclercq, P. M. Tulkens, F. van Bambeke, Antimicrob. Agents Chemother., 2003, 47, 1047.

    Article  CAS  Google Scholar 

  37. K. S. Fenner, M. D. Troutman, S. Kempshall, J. A. Cook, J. A. Ware, D. A. Smith, C. A. Lee, Clin. Pharmacol. Ther., 2009, 85,173.

    Article  CAS  Google Scholar 

  38. E. Wang, W. W. Johnson, Chemotherapy, 2003, 49,303.

    Article  CAS  Google Scholar 

  39. T. Nakanishi, Cancer Genomics Proteomics, 2007, 4,241.

    CAS  Google Scholar 

  40. M. Takano, R. Hasegawa, T. Fukuda, R. Yumoto, J. Nagai, T. Murakami, Eur. J. Pharmacol., 1998, 358,289.

    Article  CAS  Google Scholar 

  41. H. Yamazaki, T. Shimada, Drug Metab. Dispos., 1998, 26, 1053.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. LLC BioClinicum Research and Development Center, 85 Build., 2 ul. Ugreshskaya, 115088, Moscow, Russian Federation

    S. V. Nikulin & A. A. Poloznikov

  2. Department of Chemistry, M. V. Lomonosov Moscow State University, Build. 3, 1 Leninskie Gory, 119992, Moscow, Russian Federation

    E. A. Tonevitsky

Authors
  1. S. V. Nikulin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. A. Tonevitsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. A. Poloznikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. A. Poloznikov.

Additional information

Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 1, pp. 0150—0155, January, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikulin, S.V., Tonevitsky, E.A. & Poloznikov, A.A. Effect of ketoconazole on the transport and metabolism of drugs in the human liver cell model. Russ Chem Bull 66, 150–155 (2017). https://doi.org/10.1007/s11172-017-1713-z

Download citation

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11172-017-1713-z

Keywords

Search

Navigation